Patients with a rare disease called mucous membrane pemphigoid are at risk of developing squamous cell carcinoma and basal cell carcinoma, finds a new study.

as well as Principia-partnered BTK inhibitor rilzabrutinib for rare autoimmune skin disease pemphigus. It also abandoned an mRNA-based vaccine for COVID-19 and suffered delays to another COVID-19 ...

Researchers developed and used a novel blood test to diagnose and successfully treat a patient with a rare form of a severe ...

New or unexpected color changes could be a sign of an autoimmune disease or other underlying condition that requires treatment. Skin discoloration is a broad term that describes any change in your ...

Amgen AMGN announced that the FDA has approved its rare disease drug Uplizna (inebilizumab) for a new indication. The regulatory body has now approved Uplizna for the treatment of adults living ...

made the discovery by studying a rare autoimmune disease called STING-associated vasculopathy with onset in infancy (SAVI). The condition is extremely rare, occurring in one of every 1 million births.